News

• EMA Consultation: Draft guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker muscular dystrophy

  The European Medicines Agency has recently published a draft guideline on the clinical investigation of medicinal products for the treatment of Duchenne and Becker mus…
  

• TiGenix reports positive Phase IIa study results in refractory rheumatoid arthritis with allogeneic stem cell product Cx611

  “This Phase IIa cell therapy trial is a landmark study that gives us a first indication of the potential of cell therapy in rheumatoid arthritis. The positive safet…